Nuhey News

We talk about the MARKET

Global Palmer Hyperhidrosis Treatment Market Key Companies Profile: Production Capacity, Revenue, Price and Gross Margin (2018-2022)

Hyperhidrosis is a disorder that results in excessive sweating of palms, soles, or underarms. Palmer hyperhidrosis is excessive and uncontrollable hand sweating and is the most common type of hyperhidrosis. The sweating may range from mild to severe.

Fully considering the economic change by this health crisis, Medications accounting for % of the Palmer Hyperhidrosis Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Primary Focal Hyperhidrosis segment is altered to an % CAGR throughout this forecast period.

China Palmer Hyperhidrosis Treatment market size is valued at US$ million in 2021, while the North America and Europe Palmer Hyperhidrosis Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Palmer Hyperhidrosis Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

Request for a free sample or purchase this report at:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Medications
  • Surgical Treatments
  • Physiotherapy
  • Others

Segment by Application

  • Primary Focal Hyperhidrosis
  • Secondary Generalized Hyperhidrosis

By Company

  • Allergan
  • GlaxoSmithKline
  • Revance Therapeutics
  • Ulthera, Inc
  • TheraVida
  • Dermira, Inc
  • Sientra Inc
  • Medications

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479